|
OSGEPL1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.12619999999864E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.55509999994119E-07 |
| Normal-vs-Stage2 |
2.410300E-02 |
| Normal-vs-Stage3 |
2.308200E-01 |
| Normal-vs-Stage4 |
5.896400E-01 |
| Stage1-vs-Stage2 |
7.531000E-01 |
| Stage1-vs-Stage3 |
6.577200E-03 |
| Stage1-vs-Stage4 |
5.497400E-03 |
| Stage2-vs-Stage3 |
1.175240E-01 |
| Stage2-vs-Stage4 |
8.200400E-02 |
| Stage3-vs-Stage4 |
6.692400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.76630000000056E-05 |
| Normal-vs-AfricanAmerican |
9.269800E-02 |
| Normal-vs-Asian |
1.834990E-01 |
| Caucasian-vs-AfricanAmerican |
6.882600E-01 |
| Caucasian-vs-Asian |
7.102400E-01 |
| AfricanAmerican-vs-Asian |
5.724000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.236260E-02 |
| Normal-vs-Female |
4.88920000041304E-07 |
| Male-vs-Female |
2.524000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.653400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.221300E-04 |
| Normal-vs-Age(61-80Yrs) |
3.578400E-04 |
| Normal-vs-Age(81-100Yrs) |
4.410400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.406760E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.550000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.244600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.911400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.926200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.070800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.172450E-02 |
| Normal-vs-Grade 2 |
1.11550000014837E-07 |
| Normal-vs-Grade 3 |
3.324800E-03 |
| Normal-vs-Grade 4 |
1.579170E-01 |
| Grade 1-vs-Grade 2 |
6.922400E-01 |
| Grade 1-vs-Grade 3 |
1.662770E-01 |
| Grade 1-vs-Grade 4 |
4.518500E-03 |
| Grade 2-vs-Grade 3 |
1.786120E-02 |
| Grade 2-vs-Grade 4 |
3.39449999997576E-06 |
| Grade 3-vs-Grade 4 |
9.581300E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.14983627858601E-14 |
| Normal-vs-ccB subtype |
4.621200E-01 |
| ccA subtype-vs-ccB subtype |
1.66788804989437E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.170900E-04 |
| Normal-vs-N1 |
5.719000E-01 |
| N0-vs-N1 |
9.128000E-02 |
|
|
